

17 Oct 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219781

03 Oct 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219406

11 Sep 2024
// EMA
https://eudragmdp.ema.europa.eu/inspections/gmpc/searchGMPNonCompliance.do;jsessionid=EXHllEEAiuMrEENOhgqyhkLdvHd_iMehQX-P2VwRA5IrgkjwHdc-!1580700852?ctrl=searchGMPNCResultControlList&action=Drilldown¶m=172054

04 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/04/2892996/0/en/MangoRx-to-Introduce-MOJO-Pharmaceutical-Compounded-Formula-Featuring-Enclomiphene-Citrate-and-Pregnenolone-for-Treatment-of-Low-Testosterone-and-Male-Hormone-Imbalances.html

https://www.pharmacompass.com/pdf/news/sanofi-aventis-australia-prohibited-euro-med-clomid-tablets-50mg-clomiphene-citrate-blister-pack-1509604465.pdf

18 Sep 2017
// PHARMABIZ